Skip to Main Content

Paper Details

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer.
Clin Cancer Res
25
2017
Bevacizumab, Breast Cancer, Tumor, Tumor biopsies, bevacizumab, estrogen, estrogen receptor, estrogen receptor-positive tumors, luminal-B tumors, patients, transcriptome mRNA, tumor, tumor cells, whole, whole-transcriptome mRNA profiles
Author NameAffiliation
Phuong VuInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Hans Kristian Moen VollanInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Hans Kristian Moen VollanOslo University Hospital
Vessela N KristensenInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Ole Christian Lingj??rdeInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Ole Christian Lingj??rdeUniversity of Oslo
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Anne-Lise B??rresen-DaleInsitute for Clinical Medicine, University of Oslo
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Anne-Lise B??rresen-DaleInsitute for Clinical Medicine, University of Oslo
  • 1 - 10

Datasets

Release 1.2